{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2026-01-20T12:28:54.758609+00:00",
  "news": [
    {
      "title": "40 Under 40: Melissa Wagner, Amgen - Medical Marketing and Media",
      "link": "https://news.google.com/rss/articles/CBMifEFVX3lxTFBIS3BJSGRRVkF2aXBEeDY3SjMxRVJqYjdjT1R3cjUtOEpzNlhvRGxQNnUxZFZvdkR1OWxkRVRkU1E1eFAwamVzT1daS1JaSGhoR1pTWGVvTlRfamF3dkJ4UHM2aWVGUDJSalNoWnF5SVdKdndSd0pvRGNBVEk?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMifEFVX3lxTFBIS3BJSGRRVkF2aXBEeDY3SjMxRVJqYjdjT1R3cjUtOEpzNlhvRGxQNnUxZFZvdkR1OWxkRVRkU1E1eFAwamVzT1daS1JaSGhoR1pTWGVvTlRfamF3dkJ4UHM2aWVGUDJSalNoWnF5SVdKdndSd0pvRGNBVEk?oc=5\" target=\"_blank\">40 Under 40: Melissa Wagner, Amgen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Medical Marketing and Media</font>",
      "published": "2026-01-20T10:02:17+00:00",
      "source": "Medical Marketing and Media"
    },
    {
      "title": "A Look At Amgen (AMGN) Valuation After Strong Q3 Results And Pipeline Momentum - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihAFBVV95cUxQWEFheFJtN2hQbzNnTWlaU1BoLTItZUFhODZMcXlXOUVNbTVwRHhRa3plTHFYUHVBSXhNcVJCZ3h1dERWTEh0ay0wVzAzTVNva1h6dkMtbTJYcnBmZVI5TGpoZ0pjUGpRWDZJSjB3NUs2dERZNEl2bmdnNFdiSmFxdVQzTmU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihAFBVV95cUxQWEFheFJtN2hQbzNnTWlaU1BoLTItZUFhODZMcXlXOUVNbTVwRHhRa3plTHFYUHVBSXhNcVJCZ3h1dERWTEh0ay0wVzAzTVNva1h6dkMtbTJYcnBmZVI5TGpoZ0pjUGpRWDZJSjB3NUs2dERZNEl2bmdnNFdiSmFxdVQzTmU?oc=5\" target=\"_blank\">A Look At Amgen (AMGN) Valuation After Strong Q3 Results And Pipeline Momentum</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2026-01-20T01:07:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "AMGEN TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE - Amgen",
      "link": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPcjU3YXZwYlBDc1k5dHdCcnJnMlhoeC16WlZyTWQzdWpfS1JiMWlsU3kwTjVGVDgyTXlma1l1d0ZrdUF0dnVYcFBpMjhoUUlLVjRDZjZIMFV6SFN4MEgzSVJVUlZFQjRPUENkcnB3cWlfeEEwWUtFSk5hVWU5bUFLZlVmamVLYmRNWUJOV2xZYTZFOV9FVGU0NHJRTVB4VjYxWktSZXhJSDRjZjM1MEpHekxqbXpPU1FpS0p3dXItZm4?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPcjU3YXZwYlBDc1k5dHdCcnJnMlhoeC16WlZyTWQzdWpfS1JiMWlsU3kwTjVGVDgyTXlma1l1d0ZrdUF0dnVYcFBpMjhoUUlLVjRDZjZIMFV6SFN4MEgzSVJVUlZFQjRPUENkcnB3cWlfeEEwWUtFSk5hVWU5bUFLZlVmamVLYmRNWUJOV2xZYTZFOV9FVGU0NHJRTVB4VjYxWktSZXhJSDRjZjM1MEpHekxqbXpPU1FpS0p3dXItZm4?oc=5\" target=\"_blank\">AMGEN TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2026-01-12T23:45:00+00:00",
      "source": "Amgen"
    },
    {
      "title": "UPS building massive $6 million cooler - The Business Journals",
      "link": "https://news.google.com/rss/articles/CBMingFBVV95cUxNNEJDT3ZHUDh5YTJUR1NqSEpWb1paUDdwYjRUdDk5R3JJekVFbzRrLWMxUEQxV2xiQ2JUT1BXSHozaVZMSzdXREUzLW13YlR0QzZqdFp0M0JoM05GVzloQ3VzdmpkV3RsZXhwZXJ5cWdGeWFlVUZNLVFsbzREam9odjlLalRic3h0N3ZmZmJLRHZHdzlGa2NvZmdFYnU4Zw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMingFBVV95cUxNNEJDT3ZHUDh5YTJUR1NqSEpWb1paUDdwYjRUdDk5R3JJekVFbzRrLWMxUEQxV2xiQ2JUT1BXSHozaVZMSzdXREUzLW13YlR0QzZqdFp0M0JoM05GVzloQ3VzdmpkV3RsZXhwZXJ5cWdGeWFlVUZNLVFsbzREam9odjlLalRic3h0N3ZmZmJLRHZHdzlGa2NvZmdFYnU4Zw?oc=5\" target=\"_blank\">UPS building massive $6 million cooler</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Business Journals</font>",
      "published": "2026-01-20T11:41:00+00:00",
      "source": "The Business Journals"
    },
    {
      "title": "Amgen CEO says weight loss drug can address 'patient persistence issue' - CNBC",
      "link": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPZDVWNlNKbjZQcl9NZ2tSSTNyUExnUGFEbXF4d0EwX0Jsczg2WnVhbkNBcGVyTHVGNG5pWTY0ZmdaSGpVem00NDU5VXlIdWhKaEVUZ0REQkMwLVhaTlJNMThtbzdvYjBiRWxrTFR0UE5VbXZ1SDZrdXBlX0VsNE0wVDNNWU8yTjhWbGJ0SV95b21lU0hUSWhHQ0ZweG92aHpsWGZF0gGoAUFVX3lxTE9aT0Mtb29TUlNiZXZ5YldLZFJKS2J0SzJ5dmtjM3BwMzBaclI4SnJkbk1uZFpKX19PWnpHTG54UmZMbjQtSU1BblRKQUNRNUFXWGtRSGI2U2xzNERkOERuSWx2UVlraTE3Z185c1ZXUGtyZF9wNGVwdzE2Qm5FbnhZOVhMQ2ltR0VIM3N2WFFjVTlhM1hod0duX2N0aE9NdU1SZE1rMFlGcg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiowFBVV95cUxPZDVWNlNKbjZQcl9NZ2tSSTNyUExnUGFEbXF4d0EwX0Jsczg2WnVhbkNBcGVyTHVGNG5pWTY0ZmdaSGpVem00NDU5VXlIdWhKaEVUZ0REQkMwLVhaTlJNMThtbzdvYjBiRWxrTFR0UE5VbXZ1SDZrdXBlX0VsNE0wVDNNWU8yTjhWbGJ0SV95b21lU0hUSWhHQ0ZweG92aHpsWGZF0gGoAUFVX3lxTE9aT0Mtb29TUlNiZXZ5YldLZFJKS2J0SzJ5dmtjM3BwMzBaclI4SnJkbk1uZFpKX19PWnpHTG54UmZMbjQtSU1BblRKQUNRNUFXWGtRSGI2U2xzNERkOERuSWx2UVlraTE3Z185c1ZXUGtyZF9wNGVwdzE2Qm5FbnhZOVhMQ2ltR0VIM3N2WFFjVTlhM1hod0duX2N0aE9NdU1SZE1rMFlGcg?oc=5\" target=\"_blank\">Amgen CEO says weight loss drug can address 'patient persistence issue'</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">CNBC</font>",
      "published": "2026-01-13T23:46:17+00:00",
      "source": "CNBC"
    },
    {
      "title": "JPM26: Amgen touts MariTide’s weight loss, T2D potential off Phase II data - Clinical Trials Arena",
      "link": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQQ2xLZDRlUHRpLUhsSTlWWHcwU1p3NnNZN3NhbUlmZmFtVVFmWlVoNGlCMGV6Uk53RnYxMmxXMnVPaHlTMjhMNThKVHdiOTlKdm9kcW1TZk1xSTYtblRuTnlsd0Z3N1FOeDVqT1RVb1ZqQVBzWXNuZUtFQWJsTldpUnpWXzBNVDBGLXJ3?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQQ2xLZDRlUHRpLUhsSTlWWHcwU1p3NnNZN3NhbUlmZmFtVVFmWlVoNGlCMGV6Uk53RnYxMmxXMnVPaHlTMjhMNThKVHdiOTlKdm9kcW1TZk1xSTYtblRuTnlsd0Z3N1FOeDVqT1RVb1ZqQVBzWXNuZUtFQWJsTldpUnpWXzBNVDBGLXJ3?oc=5\" target=\"_blank\">JPM26: Amgen touts MariTide’s weight loss, T2D potential off Phase II data</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Clinical Trials Arena</font>",
      "published": "2026-01-14T12:22:30+00:00",
      "source": "Clinical Trials Arena"
    },
    {
      "title": "AMGEN ACQUIRES DARK BLUE THERAPEUTICS, BOLSTERING ONCOLOGY PIPELINE - PR Newswire",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPUUx5bW1JMG82U3I3c3JNMVFfNWVFcklFUUstVWNiQS0yWUdpLXBSTEE2TnlxRlRvOVhJUS1mUTdqeFEwZ3duNXZlV0dyWTNSVHhJeklDczI4aVpybkFVSXluaDA0b3g1WHdEZTJkNzVpbEw5XzNXbGlyRHd2QmV5NUNSTWVPdVVZdjZ0VUR1bHB2UkdLMDVKZkxwS3NWSkY4bUUwQlRWdG16UUFUcV8xWjdlWWhsQ2NZWXV0MjJrNA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxPUUx5bW1JMG82U3I3c3JNMVFfNWVFcklFUUstVWNiQS0yWUdpLXBSTEE2TnlxRlRvOVhJUS1mUTdqeFEwZ3duNXZlV0dyWTNSVHhJeklDczI4aVpybkFVSXluaDA0b3g1WHdEZTJkNzVpbEw5XzNXbGlyRHd2QmV5NUNSTWVPdVVZdjZ0VUR1bHB2UkdLMDVKZkxwS3NWSkY4bUUwQlRWdG16UUFUcV8xWjdlWWhsQ2NZWXV0MjJrNA?oc=5\" target=\"_blank\">AMGEN ACQUIRES DARK BLUE THERAPEUTICS, BOLSTERING ONCOLOGY PIPELINE</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
      "published": "2026-01-06T08:00:00+00:00",
      "source": "PR Newswire"
    },
    {
      "title": "Ro partners with Amgen to study barriers to obesity care, GLP-1 access - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxQUEpDQ2FuOHRlZDhZZ3ZoRUM0ejJlTktVSm1QN3J3RE02N0s2ZUZyeFBmekNyalJ2OUhhOW53MFNqWkJCLTBvTllSR0N0WTBadlNLUTNyenAya29nR0dVVE5kU3VRcWpoRktaNFJuWjh2Tm5TWTJVSXpVTTZ2NDZwQWFfZF9iUVFRNm9zSC1LSDdySEtiZzR6bUF5ZlYtSEloYTVjUzZ4V3U0TTU2TmEtX0YxR3MyS0hfT2FCaERSUlk0M1JjQW0xd0I1OTBqcWFENXhKM0hn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi1gFBVV95cUxQUEpDQ2FuOHRlZDhZZ3ZoRUM0ejJlTktVSm1QN3J3RE02N0s2ZUZyeFBmekNyalJ2OUhhOW53MFNqWkJCLTBvTllSR0N0WTBadlNLUTNyenAya29nR0dVVE5kU3VRcWpoRktaNFJuWjh2Tm5TWTJVSXpVTTZ2NDZwQWFfZF9iUVFRNm9zSC1LSDdySEtiZzR6bUF5ZlYtSEloYTVjUzZ4V3U0TTU2TmEtX0YxR3MyS0hfT2FCaERSUlk0M1JjQW0xd0I1OTBqcWFENXhKM0hn?oc=5\" target=\"_blank\">Ro partners with Amgen to study barriers to obesity care, GLP-1 access</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2026-01-13T15:23:57+00:00",
      "source": "Reuters"
    }
  ],
  "product_launches": [
    {
      "title": "AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S. - Amgen",
      "link": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxPaE9rZlFxUjZZSGd5Yk85X1ZoVGtfQ0NTYW9jV1pQLVNfbU5tUmV2NGRFdnZpaUNoLTFCV2RxNEgzTmUxdS11OHpWczc2ZDFhblp3WjB2dzZ0el9JQjgwMWFDc3dpTU5LTk5yeHZEaExDVVUwb2JBR1RDZHNTTUpaWXhFWnR6M3V5VlVhb3dENHh4LVpRMDlrNFZrWkdnOWlXTGt6cEozc1JKeEg1OW5WOWZBMjB6SFd6eFRmSTBSMl8xbmJXX0pyWk1GMllyeUZiX1E?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi0gFBVV95cUxPaE9rZlFxUjZZSGd5Yk85X1ZoVGtfQ0NTYW9jV1pQLVNfbU5tUmV2NGRFdnZpaUNoLTFCV2RxNEgzTmUxdS11OHpWczc2ZDFhblp3WjB2dzZ0el9JQjgwMWFDc3dpTU5LTk5yeHZEaExDVVUwb2JBR1RDZHNTTUpaWXhFWnR6M3V5VlVhb3dENHh4LVpRMDlrNFZrWkdnOWlXTGt6cEozc1JKeEg1OW5WOWZBMjB6SFd6eFRmSTBSMl8xbmJXX0pyWk1GMllyeUZiX1E?oc=5\" target=\"_blank\">AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2025-10-06T07:00:00+00:00",
      "source": "Amgen"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-16T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-09-08T07:00:00+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "3 major patent losses this year — and a key strategy to fill the gaps - Pharma Voice",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5\" target=\"_blank\">3 major patent losses this year — and a key strategy to fill the gaps</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Pharma Voice</font>",
      "published": "2025-07-21T07:00:00+00:00",
      "source": "Pharma Voice"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2026-01-16",
      "close": 330.4100036621094
    },
    "history": [
      {
        "date": "2026-01-08",
        "close": 330.1099853515625
      },
      {
        "date": "2026-01-09",
        "close": 326.1000061035156
      },
      {
        "date": "2026-01-12",
        "close": 325.5400085449219
      },
      {
        "date": "2026-01-13",
        "close": 324.29998779296875
      },
      {
        "date": "2026-01-14",
        "close": 328.9700012207031
      },
      {
        "date": "2026-01-15",
        "close": 330.0299987792969
      },
      {
        "date": "2026-01-16",
        "close": 330.4100036621094
      }
    ],
    "name": "Amgen Inc."
  }
}